4
Changes in Ownership
10x Genomics, Inc. Filed Acc 0001209191-21-054899
Director sold 41,666 shares at an average $177.50 ($7,395,887)
- Director acquired 41,666 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hindson Benjamin J. · Director
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-01 | Exercise or conversion : show line 1 in the form | +41,666 | $5.04 | $209,997 | 88,783 | D |
| 2021-09-01 | Sale : show line 2 in the form | −1,049 | $174.39 | $182,935 | 87,734 | D |
| 2021-09-01 | Sale : show line 3 in the form | −2,728 | $175.69 | $479,292 | 85,006 | D |
| 2021-09-01 | Sale : show line 4 in the form | −7,530 | $176.65 | $1,330,156 | 77,476 | D |
| 2021-09-01 | Sale : show line 5 in the form | −21,145 | $177.72 | $3,757,830 | 56,331 | D |
| 2021-09-01 | Sale : show line 6 in the form | −8,586 | $178.56 | $1,533,138 | 47,745 | D |
| 2021-09-01 | Sale : show line 7 in the form | −628 | $179.20 | $112,536 | 47,117 | D |
| Open-market sales · 41,666 sh · avg $177.50 · $7,395,887 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-09-01 | Exercise or conversion : show line 8 in the form Stock Option (right to buy) | −41,666 | $5.04 | 2028-11-02 | 41,666 | 102,782 | D |
Loading xslF345X03/doc4.xml…